88 related articles for article (PubMed ID: 18510960)
1. Endothelial dysfunction associated with drug-eluting stents what, where, when, and how?
Muhlestein JB
J Am Coll Cardiol; 2008 Jun; 51(22):2139-40. PubMed ID: 18510960
[No Abstract] [Full Text] [Related]
2. Sirolimus-induced vascular dysfunction. Increased mitochondrial and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production and decreased vascular nitric oxide formation.
Jabs A; Göbel S; Wenzel P; Kleschyov AL; Hortmann M; Oelze M; Daiber A; Münzel T
J Am Coll Cardiol; 2008 Jun; 51(22):2130-8. PubMed ID: 18510959
[TBL] [Abstract][Full Text] [Related]
3. Intractable Prinzmetal's angina three months after implantation of sirolimus-eluting stent.
Abe M; Yoshida A; Otsuka Y
J Invasive Cardiol; 2008 Nov; 20(11):E306-9. PubMed ID: 18987406
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion.
Hamilos MI; Ostojic M; Beleslin B; Sagic D; Mangovski L; Stojkovic S; Nedeljkovic M; Orlic D; Milosavljevic B; Topic D; Karanovic N; Wijns W;
J Am Coll Cardiol; 2008 Jun; 51(22):2123-9. PubMed ID: 18510958
[TBL] [Abstract][Full Text] [Related]
5. Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses.
Hamilos M; Sarma J; Ostojic M; Cuisset T; Sarno G; Melikian N; Ntalianis A; Muller O; Barbato E; Beleslin B; Sagic D; De Bruyne B; Bartunek J; Wijns W
Circ Cardiovasc Interv; 2008 Dec; 1(3):193-200. PubMed ID: 20031678
[TBL] [Abstract][Full Text] [Related]
6. Effects of stem cell mobilization by granulocyte colony-stimulating factor on endothelial function after sirolimus-eluting stent implantation: a double-blind, randomized, placebo-controlled clinical trial.
Iwata Y; Fujimoto Y; Morino T; Sugimoto K; Ohkubo K; Kadohira T; Fukushima K; Kitahara H; Komuro I; Kobayashi Y
Am Heart J; 2013 Mar; 165(3):408-14. PubMed ID: 23453111
[TBL] [Abstract][Full Text] [Related]
7. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent.
Kim JW; Suh SY; Choi CU; Na JO; Kim EJ; Rha SW; Park CG; Seo HS; Oh DJ
JACC Cardiovasc Interv; 2008 Feb; 1(1):65-71. PubMed ID: 19393147
[TBL] [Abstract][Full Text] [Related]
8. Persistent endothelial dysfunction after drug-eluting stents: another continuing cost of reducing restenosis.
Kern MJ
JACC Cardiovasc Interv; 2008 Feb; 1(1):72-3. PubMed ID: 19393148
[No Abstract] [Full Text] [Related]
9. Specific coronary drug-eluting stents interfere with distal microvascular function after single stent implantation in pigs.
van den Heuvel M; Sorop O; Batenburg WW; Bakker CL; de Vries R; Koopmans SJ; van Beusekom HM; Duncker DJ; Danser AH; van der Giessen WJ
JACC Cardiovasc Interv; 2010 Jul; 3(7):723-30. PubMed ID: 20650434
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4.
Liang CF; Liu JT; Wang Y; Xu A; Vanhoutte PM
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):777-84. PubMed ID: 23413427
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction after sirolimus-eluting stent placement.
Serry R; Penny WF
J Am Coll Cardiol; 2005 Jul; 46(2):237-8. PubMed ID: 16022948
[No Abstract] [Full Text] [Related]
12. Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimusand tacrolimus-eluting stents.
van Beusekom HM; Sorop O; van den Heuvel M; Onuma Y; Duncker DJ; Danser AH; van der Giessen WJ
EuroIntervention; 2010 May; 6(1):117-25. PubMed ID: 20542807
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction.
Kim JW; Seo HS; Park JH; Na JO; Choi CU; Lim HE; Kim EJ; Rha SW; Park CG; Oh DJ
J Am Coll Cardiol; 2009 May; 53(18):1653-9. PubMed ID: 19406340
[TBL] [Abstract][Full Text] [Related]
15. Morphological, Functional, and Biological Vascular Healing Response 6 Months After Drug-Eluting Stent Implantation: A Randomized Comparison of Three Drug-Eluting Stents.
Nakata T; Fujii K; Fukunaga M; Shibuya M; Kawai K; Kawasaki D; Naito Y; Ohyanagi M; Masuyama T
Catheter Cardiovasc Interv; 2016 Sep; 88(3):350-7. PubMed ID: 26526816
[TBL] [Abstract][Full Text] [Related]
16. Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine.
Ramzy D; Rao V; Tumiati LC; Xu N; Miriuka S; Delgado D; Ross HJ
Circulation; 2006 Jul; 114(1 Suppl):I214-9. PubMed ID: 16820575
[TBL] [Abstract][Full Text] [Related]
17. Drug-eluting stent-induced vascular dysfunction: common and missing links.
Jabs A; Münzel T
J Am Coll Cardiol; 2010 Mar; 55(13):1399; author reply 1399-400. PubMed ID: 20338508
[No Abstract] [Full Text] [Related]
18. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction.
Togni M; Windecker S; Cocchia R; Wenaweser P; Cook S; Billinger M; Meier B; Hess OM
J Am Coll Cardiol; 2005 Jul; 46(2):231-6. PubMed ID: 16022947
[TBL] [Abstract][Full Text] [Related]
19. Images in cardiovascular medicine. Severe endothelial dysfunction after sirolimus-eluting stent implantation.
Maekawa K; Kawamoto K; Fuke S; Yoshioka R; Saito H; Sato T; Hioka T
Circulation; 2006 Jun; 113(23):e850-1. PubMed ID: 16769919
[No Abstract] [Full Text] [Related]
20. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension.
Jung O; Schreiber JG; Geiger H; Pedrazzini T; Busse R; Brandes RP
Circulation; 2004 Apr; 109(14):1795-801. PubMed ID: 15037533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
